14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.83 $2.51 Friday, 3rd May 2024 CGEN stock ended at $2.11. This is 2.31% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.51% from a day low at $2.07 to a day high of $2.22.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
May 13, 2020 $15.29 $15.45 $13.48 $13.94 1 645 576
May 12, 2020 $15.91 $16.05 $14.44 $14.82 1 684 021
May 11, 2020 $15.41 $16.31 $15.27 $15.58 1 796 216
May 08, 2020 $14.37 $15.75 $14.19 $15.41 1 350 633
May 07, 2020 $13.48 $14.95 $13.26 $14.33 1 451 729
May 06, 2020 $14.77 $14.78 $13.04 $13.22 1 367 619
May 05, 2020 $15.13 $15.20 $14.62 $14.71 728 213
May 04, 2020 $13.89 $14.94 $13.88 $14.94 799 442
May 01, 2020 $14.02 $14.43 $13.80 $13.86 701 357
Apr 30, 2020 $14.55 $14.85 $14.07 $14.49 1 061 238
Apr 29, 2020 $13.85 $15.30 $13.79 $15.03 1 430 945
Apr 28, 2020 $14.61 $14.97 $13.72 $13.82 1 612 173
Apr 27, 2020 $15.00 $15.29 $14.42 $14.52 2 129 283
Apr 24, 2020 $13.98 $15.06 $13.98 $14.85 1 737 704
Apr 23, 2020 $15.05 $15.10 $13.85 $14.11 1 725 559
Apr 22, 2020 $14.95 $15.13 $14.30 $14.72 1 806 604
Apr 21, 2020 $14.25 $14.61 $13.40 $13.96 1 453 021
Apr 20, 2020 $13.07 $14.10 $12.84 $14.00 1 423 988
Apr 17, 2020 $13.85 $13.85 $12.70 $12.95 1 666 760
Apr 16, 2020 $12.54 $14.21 $12.28 $13.75 3 316 000
Apr 15, 2020 $10.52 $11.68 $10.39 $11.45 1 008 905
Apr 14, 2020 $9.99 $10.94 $9.95 $10.81 1 073 440
Apr 13, 2020 $9.15 $9.84 $9.05 $9.78 875 603
Apr 09, 2020 $8.95 $9.04 $8.64 $9.00 1 092 761
Apr 08, 2020 $8.35 $9.00 $8.22 $8.77 798 043
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT